News about Industrial talks

Astellas Pharma to Transfer Manufacturing Plant, Business to Delpharm

Astellas Pharma announced that Astellas B.V., Astellas Pharma Europe B.V., and Astellas’ subsidiaries in the Netherlands have decided to sell and transfer the manufacturing plant located in Meppel to Delpharm Industries.

Industrial talks | 30/05/2023 | By Sudeep Soparkar |  580

IOL Chemicals and Pharmaceuticals bags CEP for Paracetamol to export in European market

The company started commercial production of the same in 2022 in its Punjab-based facility

Industrial talks | 09/05/2023 | By Sudeep Soparkar |  612

GSK in agreement to acquire late-stage biopharma company BELLUS Health

The acquisition provides GSK access to camlipixant, a potential best-in-class and highly selective P2X3 antagonist currently in phase III development for the first-line treatment of adult patients with RCC

Industrial talks | 25/04/2023 | By Sudeep Soparkar |  745

SNBL to acquire Satsuma Pharma

SNBL will be involved in the launch of novel intranasal drug, which was developed based on SNBL’s novel intranasal drug delivery platform technology

Industrial talks | 21/04/2023 | By Sudeep Soparkar |  268

Marksans Pharma completes acquisition of manufacturing site from Tevapharm India

Expand existing manufacturing capacity in India

Industrial talks | 20/04/2023 | By Sudeep Soparkar |  1161

Jubilant Ingrevia commissions acetic anhydride plant at Bharuch, Gujarat

The enhanced capacity will also help the company to increase its global presence in various geographies and achieve a leadership position

Industrial talks | 18/04/2023 | By Sudeep Soparkar |  955

Meridian Medical Technologies invests $100+ M in Bridgeton, Missouri for expansion

Meridian, which recently combined with Kindeva, will be converting this new 155,000-square-foot facility to support increased production of drug-device combination products

Industrial talks | 13/04/2023 | By Sudeep Soparkar |  733

Cadila Pharma signs MoU worth Rs 1000 cr with Gujarat govt

As per the MoU, Government of Gujarat will facilitate Cadila Pharmaceuticals to obtain necessary permissions, registrations, approvals and clearances

Industrial talks | 23/03/2023 | By Sudeep Soparkar |  968

Cellipont Bioservices announces strategic debt facility investment from OrbiMed

The 76,000 sq foot facility will feature significant capabilities including process and analytical development and manufacturing services for CAR-T, IPSC, MSC and other types of cell therapies

Industrial talks | 22/03/2023 | By Sudeep Soparkar |  462

Eiko LifeSciences in MoU with Vivacious Pharmatex

Both companies will use their manufacturing facilities/ expanded capacities to manufacture the products identified and developed by ELL

Industrial talks | 20/03/2023 | By Sudeep Soparkar |  524